ArticleLeukemia research reports2023

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys).

Jumoke Okikiolu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.